Skip to the answer

Dapagliflozin / Metformin Uses, Dosage, Side Effects and Interactions

Brand name
Xigduo XR

Xigduo XR was the first dapagliflozin / metformin product the FDA approved, in October 2014. An FDA-approved generic with the same active ingredients is listed.

Dapagliflozin / Metformin is a two-medicine combination pill for adults with type 2 diabetes. It lowers blood sugar and, through dapagliflozin, can reduce the risk of kidney and heart problems.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About Dapagliflozin / MetforminType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Dapagliflozin / Metformin in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Dapagliflozin/metformin (Xigduo XR) is a common step up for type 2 diabetes when metformin alone is not enough. It pairs metformin, which lowers the sugar the liver makes, with dapagliflozin, which flushes extra sugar into the urine and lowers the risk of heart failure hospitalization and kidney decline in people who qualify; it has been around since about 2014, with FDA-approved generics listed. Most people handle it well, noticing mainly more frequent urination, some early stomach upset and genital yeast infections. Its boxed warning is lactic acidosis, a rare but life-threatening acid buildup from the metformin, so get emergency care for unexplained muscle pain, trouble breathing, unusual sleepiness or stomach pain.

Key Takeaways From the HelloPharmacist Team

  • Take it once a day in the morning with food, and swallow the tablet whole without crushing, cutting or chewing it.
  • Get urgent care for nausea, vomiting or stomach pain, since ketoacidosis (a dangerous acid buildup) can occur even without very high blood sugar.
  • Expect kidney blood tests before starting and regularly after, and tell whoever schedules surgery or a contrast-dye scan that you take it.
  • Drink enough fluids, especially in hot weather or when sick, since the extra urination can leave you dehydrated and dizzy.

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Dapagliflozin / Metformin.

This medicine can cause lactic acidosis, a rare but life-threatening buildup of lactic acid in the blood. It has led to death in some cases.

Symptoms can be subtle: feeling unwell, muscle aches, trouble breathing, unusual sleepiness and stomach pain. Risk is higher with kidney or liver problems, age 65 or older, heavy alcohol use, contrast dye scans, surgery, low-oxygen states like acute heart failure, mitochondrial diseases, and certain medicines such as topiramate. If you suspect it, stop the medicine and get emergency care.

Read the full warning on DailyMed →

Dapagliflozin / Metformin by the Numbers

Strengths
5
in one form
Makers and packagers
10
Earliest FDA record
2014
Rank by Medicaid prescriptions
#686 of 1,682 drugs
More prescriptions than 59% of the 1,682 drugs we measure
40,800 prescriptions, Q1–Q4 2025

Patient Information Guide for Dapagliflozin / Metformin

What It’s Used For

This combination is for adults with type 2 diabetes.

  • Improves blood sugar control along with diet and exercise.
  • Lowers the risk of kidney function decline, end-stage kidney disease, cardiovascular death and heart failure hospitalization in chronic kidney disease at risk of progression.
  • Lowers the risk of cardiovascular death, heart failure hospitalization and urgent heart failure visits in people with heart failure.
  • Lowers the risk of heart failure hospitalization in people with established cardiovascular disease or multiple cardiovascular risk factors.
  • Not for type 1 diabetes, and not for chronic kidney disease from polycystic kidney disease or after recent immunosuppressive therapy for kidney disease.

How It Works

Dapagliflozin blocks a protein in the kidneys called SGLT2, which normally pulls sugar back into the blood. Blocking it sends extra sugar out in the urine. It also affects sodium handling, which may ease strain on the heart and kidneys.

Metformin lowers sugar made by the liver, reduces sugar absorbed from the gut and helps your body use insulin better.

Drug Class

Drug Class

  • Sodium-Glucose Cotransporter 2 Inhibitor from dapagliflozin
  • Biguanide from metformin
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Dapagliflozin / Metformin has two active ingredients, so each class says which one it comes from.

Drug Class

Established Pharmacologic Class (EPC)
  • Sodium-Glucose Cotransporter 2 Inhibitor from dapagliflozin
  • Biguanide from metformin

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Sodium-Glucose Transporter 2 Inhibitors from dapagliflozin

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Dapagliflozin / Metformin in the FDA’s index.

From our Patient Information GuideDapagliflozin blocks a protein in the kidneys called SGLT2, which normally pulls sugar back into the blood. Blocking it sends extra sugar out in the urine. It also affects sodium handling, which may ease strain on the heart and kidneys. Metformin lowers sugar made by the liver, reduces sugar absorbed from the gut and helps your body use insulin better. Read How Dapagliflozin / Metformin Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)
  • Biguanides from metformin

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Combinations of oral blood glucose lowering drugs

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

This is an extended-release tablet taken by mouth once daily in the morning with food. Swallow it whole.

  • Your prescriber chooses a starting dose based on what you take now and adjusts it as needed.
  • Doses are increased gradually to ease stomach side effects.
  • Your doctor may have you stop it before contrast dye imaging or for at least 3 days before surgery or procedures with prolonged fasting, if possible.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Blood sugar control in type 2 diabetes

Adults and children 10 and older · Starting dose of dapagliflozin Starting dose 5 mg once a day Highest dose 10 mg of dapagliflozin a day
  • 5 mg orally once daily (dapagliflozin in Xigduo XR), in the morning with food

Good to know

Dosage may be adjusted based on effectiveness and tolerability

Adults and children 10 and older · Starting dose of metformin Starting dose 500 mg of metformin extended-release once a day Highest dose 2,000 mg of metformin extended-release a day
  • 500 mg orally once daily (metformin HCl extended-release in Xigduo XR), in the morning with food

Good to know

Gradual dosage escalation to reduce gastrointestinal adverse reactions; patients taking an evening dosage of metformin HCl extended-release should skip their last dose before starting

Adults with heart failure or chronic kidney disease (dapagliflozin dosage)

Usual dose 10 mg of dapagliflozin once a day Highest dose 10 mg of dapagliflozin a day

Other Doses

Adults with mildly reduced kidney function (eGFR 45 or higher) Same as the recommended dosage in patients with normal renal function

Good to know

Initiation not recommended with eGFR between 30 and 45 mL/min/1.73 m2; contraindicated with eGFR below 30 mL/min/1.73 m2

eGFR means estimated glomerular filtration rate, a measure of how well the kidneys work.

See the Full Dosing Instructions on DailyMed →

Side Effects

Common side effects include:

Common side effects

  • Genital yeast infections (more common in women, also seen in men)
  • Urinary tract infections
  • Diarrhea
  • Nausea or vomiting
  • Headache
  • Stuffy or runny nose and sore throat (nasopharyngitis)
  • Increased urination

When to get medical help

  • Get emergency help for unusual muscle pain, extreme tiredness, trouble breathing, unusual sleepiness, stomach pain, or feeling cold or dizzy. These can be signs of lactic acidosis.
  • Get help right away for nausea, vomiting, stomach pain, unusual tiredness or shortness of breath. These can signal ketoacidosis, even when blood sugar is not very high.
  • Seek care right away for pain, tenderness, redness or swelling in the genital or buttock area with fever or feeling unwell. This can be a rare, serious infection (Fournier’s gangrene).
  • Call your doctor about signs of dehydration or low blood pressure, such as dizziness or fainting.
  • Call your doctor about signs of a urinary or genital infection.
  • Seek help for a serious allergic reaction, such as swelling of the face or throat or trouble breathing.

Seek help quickly for signs of lactic acidosis, ketoacidosis, dehydration, a severe genital or perineal infection, or a serious allergic reaction.

Warnings and Precautions

  • Lactic acidosis (boxed warning): rare but can be fatal. Risk is higher with kidney or liver problems, age 65 or older, heavy alcohol use, and contrast dye scans.
  • Ketoacidosis: can happen even with near-normal blood sugar. Risk rises with illness, reduced eating, surgery, dehydration or alcohol misuse.
  • Dehydration and low blood pressure, and in some cases acute kidney injury.
  • Serious genital and urinary infections, including Fournier’s gangrene.
  • Low blood sugar when used with insulin or sulfonylureas.
  • Low vitamin B12 from metformin, so your doctor will check blood counts yearly.

Interactions

Tell your pharmacist about all your medicines. Key ones include:

  • Alcohol: raises lactic acidosis risk.
  • Topiramate, zonisamide, acetazolamide, dichlorphenamide: may raise lactic acidosis risk.
  • Ranolazine, vandetanib, dolutegravir, cimetidine: can increase metformin levels.
  • Insulin or sulfonylureas: higher risk of low blood sugar.
  • Diuretics, corticosteroids, estrogens, birth control pills, thyroid products and other drugs that can raise blood sugar.
  • Lithium: levels may fall.
  • Urine glucose tests will read positive, so they can’t track your control.

Interactions Listed in the FDA-Approved Label

From the Dapagliflozin / Metformin prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Carbonic anhydrase inhibitors (topiramate, zonisamide, acetazolamide, dichlorphenamide)
    What happensThey often lower serum bicarbonate and cause non-anion gap, hyperchloremic metabolic acidosis, which may increase the risk of lactic acidosis.
    What to doConsider more frequent monitoring.
  • Drugs that reduce metformin clearance (ranolazine, vandetanib, dolutegravir, cimetidine; OCT2/MATE inhibitors)
    What happensThey could increase metformin exposure and may increase the risk of lactic acidosis.
    What to doConsider the benefits and risks of concomitant use.
  • Alcohol
    What happensAlcohol is known to potentiate the effect of metformin on lactate metabolism.
    What to doWarn patients against excessive alcohol intake.
  • Insulin or insulin secretagogues For example: sulfonylurea
    What happensThe risk of hypoglycemia may be increased.
    What to doConcomitant use may require lower doses of insulin or the insulin secretagogue.
  • Drugs affecting glycemic control (thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, isoniazid)
    What happensThese drugs tend to produce hyperglycemia and may lead to loss of glycemic control.
    What to doObserve closely for loss of blood glucose control when started, and for hypoglycemia when withdrawn.
  • What happensConcomitant use of an SGLT2 inhibitor with lithium may decrease serum lithium concentrations.
    What to doMonitor serum lithium concentration more frequently during initiation and dosage changes.
  • Positive urine glucose test
    What happensSGLT2 inhibitors increase urinary glucose excretion and will lead to positive urine glucose tests.
    What to doMonitoring glycemic control with urine glucose tests is not recommended; use alternative methods.
  • 1,5-anhydroglucitol (1,5-AG) assay
    What happensMeasurements of 1,5-AG are unreliable in assessing glycemic control in patients taking SGLT2 inhibitors.
    What to doMonitoring with the 1,5-AG assay is not recommended; use alternative methods.
Read the label’s full interactions text

7 DRUG INTERACTIONS Table 6: Clinically Relevant Interactions with Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact Topiramate or other carbonic anhydrase inhibitors (e.g., zonisamide, acetazolamide or dichlorphenamide) frequently causes a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with dapagliflozin and metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis. Intervention Consider more frequent monitoring of these patients. Drugs that Reduce Metformin Clearance Clinical Impact Concomitant use of drugs that interfere with common renal tubular transport systems involved in the renal elimination of metformin (e.g., organic cationic transporter-2 [OCT2]/multidrug and toxin extrusion [MATE] inhibitors, such as ranolazine, vandetanib, dolutegravir, and cimetidine) could increase systemic exposure to metformin and may increase the risk for lactic acidosis. Intervention Consider the benefits and risks of concomitant use. Alcohol Clinical Impact Alcohol is known to potentiate the effect of metformin on lactate metabolism. Intervention Warn patients against excessive alcohol intake while receiving dapagliflozin and metformin hydrochloride extended-release tablets. Insulin or Insulin Secretagogues Clinical Impact The risk of hypoglycemia may be increased when dapagliflozin and metformin hydrochloride extended-release tablet is used concomitantly with insulin or insulin secretagogues (e.g., sulfonylurea). Intervention Concomitant use may require lower doses of insulin or the insulin secretagogue to reduce the risk of hypoglycemia. Drugs Affecting Glycemic Control Clinical Impact Certain drugs tend to produce hyperglycemia and may lead to loss of glycemic control.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use with severe kidney disease (eGFR below 30), end-stage kidney disease, metabolic acidosis or ketoacidosis, or a past serious allergy to its ingredients.
  • Avoid with liver disease.
  • Not recommended with mitochondrial diseases such as MELAS or MIDD.
  • Not for type 1 diabetes.
  • Not recommended in the second and third trimesters of pregnancy or while breastfeeding.
  • Older adults have more low blood pressure and need more frequent kidney checks.
  • Tell your doctor about dehydration, diuretic use, heart failure, or genital or urinary infections.

Overdose

Metformin overdose can cause lactic acidosis, which happened in about 32% of reported overdose cases. Call Poison Help at 1-800-222-1222 or seek emergency care. Hemodialysis may help remove metformin.

Half-Life and How Your Body Processes It

Food does not change the overall absorption of either medicine in this tablet. Dapagliflozin has a half-life of about 12.9 hours and is mostly broken down into an inactive form, then cleared mainly through the kidneys. Metformin is not metabolized by the liver and leaves the body unchanged in urine, with about 90% of absorbed drug cleared within 24 hours. That is why kidney function matters so much.

Storage

Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F).

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Dapagliflozin / Metformin: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Dapagliflozin / Metformin — the kind of thing our pharmacy team would talk through with you at the counter.

What is dapagliflozin / metformin used for?

It helps control blood sugar in adults with type 2 diabetes, along with diet and exercise. The dapagliflozin part can also lower the risk of heart failure hospitalization and kidney decline in people who qualify. It is not for type 1 diabetes.

How should I take dapagliflozin / metformin?

Take it once a day in the morning with food. Swallow the tablet whole and never crush, cut or chew it. Follow the dose your prescriber gave you.

What side effects should I expect?

The most common are genital yeast infections, urinary infections, diarrhea, nausea, headache and more frequent urination. Call your doctor if you notice signs of infection. Get urgent help for stomach pain, vomiting, trouble breathing, extreme tiredness or genital pain with fever.

Can I drink alcohol while taking dapagliflozin / metformin?

Avoid heavy drinking. Alcohol boosts metformin’s effect on lactate and raises the risk of lactic acidosis, a serious problem.

Do I need to stop it before surgery or a scan with contrast dye?

Possibly. You may need to stop it at or before contrast dye imaging, and for at least 3 days before surgery or procedures with prolonged fasting, if possible. Tell your care team you take it so they can plan with you.

Is dapagliflozin / metformin safe in pregnancy?

It is not recommended in the second and third trimesters, and not recommended while breastfeeding. Talk to your doctor if you are pregnant, plan to be, or are nursing.

Is dapagliflozin / metformin available over the counter?

No. Dapagliflozin / metformin is a prescription medicine: every dapagliflozin / metformin product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was dapagliflozin / metformin first available?

The earliest FDA record we hold for dapagliflozin / metformin is from 2014: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when dapagliflozin / metformin was first used.

Who makes dapagliflozin / metformin?

10 companies currently list dapagliflozin / metformin products in the FDA's NDC Directory, including AstraZeneca Pharmaceuticals LP, Ascend Laboratories, LLC, Aurobindo Pharma Limited. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of dapagliflozin / metformin?

Dapagliflozin / metformin is the generic name. Its brand name is Xigduo XR. Generic versions are listed under the name dapagliflozin / metformin.

What is the generic name of Xigduo XR?

The generic name of Xigduo XR is dapagliflozin / metformin. A generic name is the name of the active ingredients, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is dapagliflozin / metformin?

Dapagliflozin / metformin belongs to the drug class Biguanide and Sodium-Glucose Cotransporter 2 Inhibitor, its established pharmacologic class on the FDA label. The FDA also groups it by how it works: Sodium-Glucose Transporter 2 Inhibitor.

Is there a generic version of dapagliflozin / metformin?

Yes. FDA-approved generic versions of dapagliflozin / metformin are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does dapagliflozin / metformin come in?

Dapagliflozin / metformin is listed in the FDA's National Drug Code Directory in these forms and strengths. Extended-release tablet (by mouth): 2.5 mg/1000 mg, 5 mg/500 mg, 5 mg/1000 mg, 10 mg/500 mg and 10 mg/1000 mg. A listing does not mean every pharmacy stocks every strength.

How much does dapagliflozin / metformin cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $0.47 to $0.80 per generic extended-release tablet across 6 strengths and $9.59 to $19.24 per extended-release tablet of brand-name Xigduo XR across 5 strengths as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Where can I read the dapagliflozin / metformin prescribing information (package insert)?

The full FDA-approved prescribing information for dapagliflozin / metformin, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Aurobindo Pharma Limited's, revised Sep 2, 2026, and links to it on DailyMed.

Can you crush dapagliflozin / metformin?

One form of dapagliflozin / metformin is on our Do Not Crush list of tablets and capsules that should not be crushed or chewed: Xigduo XR (tablet, extended release). An extended-release form releases the medicine over many hours, and crushing or chewing it can release the whole dose at once. A form that is not on the list may still come with its own instructions, so check the label and ask your pharmacist before you crush, split or open any medicine. Each listed form’s reason and instructions are on our Do Not Crush list.

Is dapagliflozin / metformin gluten free?

No dapagliflozin / metformin label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 37 dapagliflozin / metformin products from 10 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's dapagliflozin / metformin by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See dapagliflozin / metformin inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Dapagliflozin / Metformin

Skip the scrolling. Ask in your own words and get an answer from Dapagliflozin / Metformin’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Dapagliflozin / Metformin’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Dapagliflozin / Metformin on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Dapagliflozin / Metformin Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Dapagliflozin / Metformin Forms and Strengths (How It Comes)

Dapagliflozin / Metformin comes in 1 dose form, the extended-release tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Dapagliflozin / Metformin inactive ingredients by manufacturer.

Extended-release tablet

By mouth
Brands Xigduo XR (the first brand, 2014)
How this form is used
What it may be used for
  • Dapagliflozin and Metformin Hydrochloride extended-release tablets are used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.
  • Dapagliflozin and Metformin Hydrochloride extended-release tablets also reduce the risk of kidney decline, cardiovascular death and heart failure hospitalization in certain adults with type 2 diabetes.
Important instructions
  • Dapagliflozin and Metformin Hydrochloride extended-release tablets are taken by mouth once daily in the morning with food.
  • Swallow Dapagliflozin and Metformin Hydrochloride extended-release tablets whole. Never crush, cut or chew them.
  • If you take evening metformin extended-release, skip your last dose before starting Dapagliflozin and Metformin Hydrochloride.
Available strengths 9 strengths
Show 3 more strengths Show fewer strengths
37 FDA-listed product records ⓘ

Dapagliflozin / Metformin on the U.S. Market: Products, Makers and Brands

How Dapagliflozin / Metformin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

10 companies list 37 Dapagliflozin / Metformin product records with the FDA, mostly as extended-release tablet; the earliest marketing or approval year on record is 2014. The one brand name in the directory today is Xigduo XR; the rest are generics.

1
Dose forms ⓘ
10
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
37
FDA-listed product records ⓘ
2014
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Unfinished tablet, film coated, extended release (5) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

AstraZeneca Pharmaceuticals LP14%
Ascend Laboratories, LLC11%
Aurobindo Pharma Limited11%
Lupin Pharmaceuticals, Inc.11%
Macleods Pharmaceuticals Limited11%
Micro Labs Limited11%
Other makers32%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Dapagliflozin / Metformin Is Used (Medicaid Data)

How many Dapagliflozin / Metformin prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

40,800
Medicaid prescriptions filled (Q1–Q4 2025)
$30M paid by Medicaid, before rebates

How commonly is Dapagliflozin / Metformin prescribed? Of the 1,682 medications we measure, Dapagliflozin / Metformin ranks #686 by Medicaid prescriptions — more than 59% of them.

Where Dapagliflozin / Metformin ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Dapagliflozin / Metformin product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 5 mg / 1000 mg 24 hr extended release oral tablet is the most-dispensed Dapagliflozin / Metformin product — about 48% of these Medicaid prescriptions.

24 HR dapagliflozin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet Most dispensed

19,405 Medicaid prescriptions (Q1–Q4 2025) 48% of Dapagliflozin / Metformin prescriptions shown $13.1M paid by Medicaid, before rebates ≈ $677 per prescription, before rebates

2 of 24 listed NDCs had Medicaid claims. RxNorm 1593070

24 HR dapagliflozin 10 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet

17,102 Medicaid prescriptions (Q1–Q4 2025) 42% of Dapagliflozin / Metformin prescriptions shown $12.9M paid by Medicaid, before rebates ≈ $752 per prescription, before rebates

2 of 23 listed NDCs had Medicaid claims. RxNorm 1593058

24 HR dapagliflozin 5 MG / metformin hydrochloride 500 MG Extended Release Oral Tablet

2,239 Medicaid prescriptions (Q1–Q4 2025) 5% of Dapagliflozin / Metformin prescriptions shown $2.3M paid by Medicaid, before rebates ≈ $1,020 per prescription, before rebates

1 of 16 listed NDCs had Medicaid claims. RxNorm 1593072

24 HR dapagliflozin 10 MG / metformin hydrochloride 500 MG Extended Release Oral Tablet

1,523 Medicaid prescriptions (Q1–Q4 2025) 4% of Dapagliflozin / Metformin prescriptions shown $1.3M paid by Medicaid, before rebates ≈ $881 per prescription, before rebates

1 of 20 listed NDCs had Medicaid claims. RxNorm 1593068

24 HR dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet

531 Medicaid prescriptions (Q1–Q4 2025) 1% of Dapagliflozin / Metformin prescriptions shown $406,819 paid by Medicaid, before rebates ≈ $766 per prescription, before rebates

1 of 3 listed NDCs had Medicaid claims. RxNorm 1940496

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 7 of the 86 listed Dapagliflozin / Metformin NDCs had Medicaid claims.

Compare Dapagliflozin / Metformin Products

A representative set of FDA-listed product records for Dapagliflozin / Metformin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 37 of 37 products — FDA National Drug Code Directory. See every product, package size and price: browse all 37 Dapagliflozin / Metformin NDCs →

Dapagliflozin / Metformin Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Dapagliflozin / Metformin recalls since July 2021.

✅No Dapagliflozin / Metformin recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Dapagliflozin / Metformin in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one exact combination of ingredients (MIN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. A different combination is a different concept with its own page.

Dose forms
1
Strengths
5
Forms in current FDA listings
1 of 1
In current FDA listings No current FDA listing
Multiple ingredients (MIN) Dapagliflozin / Metformin RxCUI 1486436

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Dapagliflozin / Metformin Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Dapagliflozin / Metformin: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick the generic or the brand and a strength to see how its price has changed since Nov 2023.

Version
Strength

At this strength, Xigduo XR costs pharmacies $9.59 per tablet.

For the generic DAPAGLIFLOZIN PROPANEDIOL 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg extended-release tablet, pharmacies paid an average of $0.469 per tablet as of Nov 18, 2026, down 92% from $5.84 a year earlier. At this strength, Xigduo XR costs pharmacies $9.59 per tablet.

What pharmacies pay now
$0.469
per tablet, as of Nov 18, 2026
Last 4 weeks
Down 3.7%
from $0.487 on Oct 21, 2026
Last 12 months
Down 92%
from $5.84 on Nov 19, 2025
Lowest and highest since Apr 2024
$0.461 to $5.92
per tablet

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic DAPAGLIFLOZIN PROPANEDIOL 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg extended-release tablet: the average pharmacy price per tablet, the last survey of each month
MonthPharmacy price
Nov 2026$0.469
Oct 2026$0.487
Sep 2026$0.461
Aug 2026$0.475
Jul 2026$0.475
Jun 2026$5.83
May 2026$5.84
Apr 2026$5.88
Mar 2026$5.90
Feb 2026$5.90
Jan 2026$5.86
Dec 2025$5.85
Nov 2025$5.84
Oct 2025$5.87
Sep 2025$5.89
Aug 2025$5.91
Jul 2025$5.92
Jun 2025$5.90
May 2025$5.87
Apr 2025$5.86
Mar 2025$5.83
Feb 2025$5.78
Jan 2025$5.75
Dec 2024$5.77
Nov 2024$5.77
Oct 2024$5.84
Sep 2024$5.83
Aug 2024$5.85
Jul 2024$5.67
Jun 2024$5.66
May 2024$5.57
Apr 2024$5.54
See all 11 prices in a table
FormStrengthVersion What pharmacies pay
Extended-release tablet · Oral DAPAGLIFLOZIN PROPANEDIOL 2.5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg Xigduo XR (brand) $9.62 per tablet NDC details & price history
Extended-release tablet · Oral DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg Generic $0.718 per tablet NDC details & price history
Extended-release tablet · Oral DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg Generic $0.469 per tablet NDC details & price history
Extended-release tablet · Oral DAPAGLIFLOZIN PROPANEDIOL 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg Xigduo XR (brand) $19.17 per tablet NDC details & price history
Extended-release tablet · Oral DAPAGLIFLOZIN PROPANEDIOL 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg Generic $0.469 per tablet NDC details & price history
Extended-release tablet · Oral DAPAGLIFLOZIN PROPANEDIOL 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg Xigduo XR (brand) $9.59 per tablet NDC details & price history
Extended-release tablet · Oral DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 500 mg Generic $0.736 per tablet NDC details & price history
Extended-release tablet · Oral DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg Generic $0.802 per tablet NDC details & price history
Extended-release tablet · Oral DAPAGLIFLOZIN PROPANEDIOL 10 mg/1; METFORMIN HYDROCHLORIDE 500 mg Xigduo XR (brand) $19.24 per tablet NDC details & price history
Extended-release tablet · Oral DAPAGLIFLOZIN PROPANEDIOL 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg Generic $0.802 per tablet NDC details & price history
Extended-release tablet · Oral DAPAGLIFLOZIN PROPANEDIOL 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg Xigduo XR (brand) $19.20 per tablet NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Dapagliflozin / Metformin Brand Names

Dapagliflozin / Metformin has one brand name on record: Xigduo XR. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Xigduo XR the first brand, 2014

Who Makes Dapagliflozin / Metformin: Manufacturers and Labelers

10 companies list Dapagliflozin / Metformin products with the FDA. By number of product records, the largest are AstraZeneca Pharmaceuticals LP, Ascend Laboratories, LLC, Aurobindo Pharma Limited. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

AstraZeneca Pharmaceuticals LP 5 Ascend Laboratories, LLC 4 Aurobindo Pharma Limited 4 Lupin Pharmaceuticals, Inc. 4 Macleods Pharmaceuticals Limited 4 Micro Labs Limited 4 Novadoz Pharmaceuticals LLC 4 Golden State Medical Supply, Inc. 3 Sun Pharmaceutical Industries, Inc. 3 Prasco Laboratories 2

Sources for This Dapagliflozin / Metformin Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Sep 2, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Dapagliflozin / Metformin.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 10 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
10
Finished products in the current FDA directory
37
Companies listing them (makers, repackagers, distributors)
10
FDA labeler codes behind them ⓘ
10
Linked representative label ⓘ
Aurobindo Pharma Limited
Linked label effective
Sep 2, 2026
Composite sections available
24
Linked SPL Set ID
513bdf9f-774c-4f7f-935a-54d3885e80a4
Linked SPL Document ID
8800b2c7-e3be-4205-913f-466e0ea9cb66
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Aurobindo Pharma Limited is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →